ceritinib
(VERWOWGGCGHDQE-UHFFFAOYSA-N)
Structure
- SMILES
- CC(Oc1cc(C2CCNCC2)c(cc1Nc1ncc(c(n1)Nc1ccccc1S(=O)(=O)C(C)C)Cl)C)C
- Type(s)
- Approved
- ATC code(s)
- L01XE28
- Molecular Formula:
- C28H36ClN5O3S
- Molecular Weight:
- 558.135
- Log P:
- 7.9175
- Hydrogen Bond Acceptor:
- 6
- Hydrogen Bond Donor:
- 3
- TPSA:
- 113.62
- CAS Number(s):
- 1032900-25-6; 1190399-48-4
Synonym(s)
1.
ceritinib
2.
5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine
3.
LDK378
4.
Zykadia
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Malignant neoplasm progression | FAERS: 275 Canada Vigilance: 5 | Canada Vigilance US FAERS | |
| 2 | Nausea | FAERS: 191 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 3 | Vomiting | FAERS: 124 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 4 | Disease Progression | FAERS: 78 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 5 | Abdominal Pain | FAERS: 59 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 6 | Fatigue | FAERS: 54 Canada Vigilance: 7 | Canada Vigilance US FAERS | |
| 7 | Malaise | FAERS: 36 Canada Vigilance: 4 | Canada Vigilance US FAERS | |
| 8 | Chest Pain | FAERS: 35 | US FAERS | |
| 9 | General physical health deterioration | FAERS: 34 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 10 | Alanine Aminotransferase Increased | FAERS: 33 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 11 | Aspartate Aminotransferase Increased | FAERS: 30 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 12 | Blood creatinine increased | FAERS: 30 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 13 | Pneumonia | FAERS: 29 | US FAERS | |
| 14 | Drug ineffective | FAERS: 28 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 15 | Pericardial effusion | FAERS: 27 | US FAERS | |
| 16 | Blood alkaline phosphatase increased | FAERS: 26 | US FAERS | |
| 17 | Pericarditis | FAERS: 26 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 18 | Weight decreased | FAERS: 25 | US FAERS | |
| 19 | Asthenia | FAERS: 22 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 20 | Constipation | FAERS: 20 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 21 | Gamma-Glutamyltransferase Increased | FAERS: 19 | US FAERS | |
| 22 | Abdominal discomfort | FAERS: 18 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 23 | Pneumonitis | FAERS: 18 | US FAERS | |
| 24 | Dehydration | FAERS: 16 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 25 | Headache | FAERS: 16 | US FAERS | |
| 26 | Dizziness | FAERS: 13 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 27 | Pulmonary Embolism | FAERS: 13 | US FAERS | |
| 28 | Blood glucose increased | FAERS: 12 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 29 | Pain | FAERS: 12 | US FAERS | |
| 30 | Feeling abnormal | FAERS: 11 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 31 | Gastrointestinal toxicity | FAERS: 10 | US FAERS | |
| 32 | Infection | FAERS: 10 | US FAERS | |
| 33 | Arthralgia | FAERS: 9 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 34 | Drug resistance | FAERS: 9 | US FAERS | |
| 35 | Nasopharyngitis | FAERS: 9 | US FAERS | |
| 36 | Product use issue | FAERS: 9 | US FAERS | |
| 37 | Transaminases increased | FAERS: 9 | US FAERS | |
| 38 | Central nervous system lesion | FAERS: 8 | US FAERS | |
| 39 | Myalgia | FAERS: 8 | US FAERS | |
| 40 | Pleuritic pain | FAERS: 8 | US FAERS | |
| 41 | Urinary tract infection | FAERS: 8 | US FAERS | |
| 42 | Altered state of consciousness | FAERS: 7 | US FAERS | |
| 43 | Neutropenia | FAERS: 7 | US FAERS | |
| 44 | Thrombosis | FAERS: 7 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 45 | Wrong technique in product usage process | FAERS: 7 | US FAERS | |
| 46 | Acute kidney injury | FAERS: 6 | US FAERS | |
| 47 | Appendicitis | FAERS: 6 | US FAERS | |
| 48 | Back Pain | FAERS: 6 | US FAERS | |
| 49 | Cholestasis | FAERS: 6 | US FAERS | |
| 50 | Dysgeusia | FAERS: 6 | US FAERS | |
| 51 | Hepatotoxicity | FAERS: 6 | US FAERS | |
| 52 | Intestinal Perforation | FAERS: 6 | US FAERS | |
| 53 | Myocardial Infarction | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 54 | Product use in unapproved indication | FAERS: 6 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 55 | Respiratory Failure | FAERS: 6 | US FAERS | |
| 56 | White blood cell count decreased | FAERS: 6 | US FAERS | |
| 57 | Atrial Fibrillation | FAERS: 5 | US FAERS | |
| 58 | Bronchitis | FAERS: 5 | US FAERS | |
| 59 | Cardiac Tamponade | FAERS: 5 | US FAERS | |
| 60 | Cerebral Infarction | FAERS: 5 | US FAERS | |
| 61 | Cerebrovascular accident | FAERS: 5 | US FAERS | |
| 62 | Cholangitis | FAERS: 5 | US FAERS | |
| 63 | Flatulence | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 64 | Hepatitis | FAERS: 5 | US FAERS | |
| 65 | Ileus | FAERS: 5 | US FAERS | |
| 66 | Influenza | FAERS: 5 | US FAERS | |
| 67 | Metastasis | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 68 | Musculoskeletal Pain | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 69 | Pancreatitis | FAERS: 5 | US FAERS | |
| 70 | Peripheral swelling | FAERS: 5 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 71 | Sepsis | FAERS: 5 | US FAERS | |
| 72 | Thrombocytopenia | FAERS: 5 | US FAERS | |
| 73 | Toxicity to various agents | FAERS: 5 | US FAERS | |
| 74 | Visual Impairment | FAERS: 5 | US FAERS | |
| 75 | Alopecia | FAERS: 4 | US FAERS | |
| 76 | Amylase increased | FAERS: 4 | US FAERS | |
| 77 | Cholecystitis | FAERS: 4 | US FAERS | |
| 78 | Concomitant disease aggravated | FAERS: 4 | US FAERS | |
| 79 | Diabetes Mellitus | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 80 | Dyspepsia | FAERS: 4 | US FAERS | |
| 81 | Enterocolitis | FAERS: 4 | US FAERS | |
| 82 | Erythema | FAERS: 4 | US FAERS | |
| 83 | Gastritis | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 84 | Lower respiratory tract infection | FAERS: 4 | US FAERS | |
| 85 | Meningitis | FAERS: 4 | US FAERS | |
| 86 | Oral pain | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 87 | Performance status decreased | FAERS: 4 | US FAERS | |
| 88 | Pleurisy | FAERS: 4 | US FAERS | |
| 89 | Respiratory distress | FAERS: 4 | US FAERS | |
| 90 | Somnolence | FAERS: 4 | US FAERS | |
| 91 | Thirst | FAERS: 4 | US FAERS | |
| 92 | Thrombocytosis | FAERS: 4 | US FAERS | |
| 93 | Anxiety | FAERS: 3 | US FAERS | |
| 94 | Ascites | FAERS: 3 | US FAERS | |
| 95 | Blood lactate dehydrogenase increased | FAERS: 3 | US FAERS | |
| 96 | Blood potassium decreased | FAERS: 3 | US FAERS | |
| 97 | Bone pain | FAERS: 3 | US FAERS | |
| 98 | Bradycardia | FAERS: 3 | US FAERS | |
| 99 | Cachexia | FAERS: 3 | US FAERS | |
| 100 | Cell Death | FAERS: 3 | US FAERS | |
| 101 | Chest discomfort | FAERS: 3 | US FAERS | |
| 102 | Concomitant disease progression | FAERS: 3 | US FAERS | |
| 103 | Depressed Level of Consciousness | FAERS: 3 | US FAERS | |
| 104 | Diabetic Ketoacidosis | FAERS: 3 | US FAERS | |
| 105 | Drug effect incomplete | FAERS: 3 | US FAERS | |
| 106 | Dysarthria | FAERS: 3 | US FAERS | |
| 107 | Ejection Fraction Decreased | FAERS: 3 | US FAERS | |
| 108 | Epilepsy | FAERS: 3 | US FAERS | |
| 109 | Gastrointestinal obstruction | FAERS: 3 | US FAERS | |
| 110 | Incorrect dose administered | FAERS: 3 | US FAERS | |
| 111 | Intussusception | FAERS: 3 | US FAERS | |
| 112 | Leukocytosis | FAERS: 3 | US FAERS | |
| 113 | Lymphadenopathy | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 114 | Metastases to adrenals | FAERS: 3 | US FAERS | |
| 115 | Neck Pain | FAERS: 3 | US FAERS | |
| 116 | No adverse event | FAERS: 3 | US FAERS | |
| 117 | Non-small cell lung cancer stage IIIB | FAERS: 3 | US FAERS | |
| 118 | Palpitations | FAERS: 3 | US FAERS | |
| 119 | Peritonitis | FAERS: 3 | US FAERS | |
| 120 | Product physical issue | FAERS: 3 | US FAERS | |
| 121 | Pyelonephritis | FAERS: 3 | US FAERS | |
| 122 | Rhabdomyolysis | FAERS: 3 | US FAERS | |
| 123 | Tachycardia | FAERS: 3 | US FAERS | |
| 124 | Therapy partial responder | FAERS: 3 | US FAERS | |
| 125 | Urticaria | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 126 | Wheezing | FAERS: 3 | US FAERS | |
| 127 | Adenocarcinoma | FAERS: 2 | US FAERS | |
| 128 | Ageusia | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 129 | Blood bilirubin unconjugated increased | FAERS: 2 | US FAERS | |
| 130 | Blood creatine increased | FAERS: 2 | US FAERS | |
| 131 | Blood creatine phosphokinase increased | FAERS: 2 | US FAERS | |
| 132 | Blood sodium decreased | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 133 | Bone lesion | FAERS: 2 | US FAERS | |
| 134 | Carcinoembryonic antigen increased | FAERS: 2 | US FAERS | |
| 135 | Cardiac Arrest | FAERS: 2 | US FAERS | |
| 136 | Cardiomegaly | FAERS: 2 | US FAERS | |
| 137 | Cellulitis | FAERS: 2 | US FAERS | |
| 138 | Cerebral disorder | FAERS: 2 | US FAERS | |
| 139 | Cholelithiasis | FAERS: 2 | US FAERS | |
| 140 | Chronic gastritis | FAERS: 2 | US FAERS | |
| 141 | Cold sweat | FAERS: 2 | US FAERS | |
| 142 | Cystitis | FAERS: 2 | US FAERS | |
| 143 | Disseminated Intravascular Coagulation | FAERS: 2 | US FAERS | |
| 144 | Dry skin | FAERS: 2 | US FAERS | |
| 145 | Eczema | FAERS: 2 | US FAERS | |
| 146 | Epididymitis | FAERS: 2 | US FAERS | |
| 147 | Failure to Thrive | FAERS: 2 | US FAERS | |
| 148 | Fibrosis | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 149 | Fluid overload | FAERS: 2 | US FAERS | |
| 150 | Food Poisoning | FAERS: 2 | US FAERS | |
| 151 | Gait inability | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 152 | Gastrointestinal Pain | FAERS: 2 | US FAERS | |
| 153 | Gastrointestinal infection | FAERS: 2 | US FAERS | |
| 154 | General physical condition abnormal | FAERS: 2 | US FAERS | |
| 155 | Hemiplegia | FAERS: 2 | US FAERS | |
| 156 | Hepatic necrosis | FAERS: 2 | US FAERS | |
| 157 | Inappropriate schedule of drug administration | FAERS: 2 | US FAERS | |
| 158 | Incorrect route of drug administration | FAERS: 2 | US FAERS | |
| 159 | Inflammation | FAERS: 2 | US FAERS | |
| 160 | Intestinal Obstruction | FAERS: 2 | US FAERS | |
| 161 | Lethargy | FAERS: 2 | US FAERS | |
| 162 | Limb discomfort | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 163 | Lipase increased | FAERS: 2 | US FAERS | |
| 164 | Metastatic Neoplasm | FAERS: 2 | US FAERS | |
| 165 | Musculoskeletal stiffness | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 166 | Neutrophil count decreased | FAERS: 2 | US FAERS | |
| 167 | Night sweats | FAERS: 2 | US FAERS | |
| 168 | Oral candidiasis | FAERS: 2 | US FAERS | |
| 169 | Osteoporosis | FAERS: 2 | US FAERS | |
| 170 | Palpable purpura | FAERS: 2 | US FAERS | |
| 171 | Pancreatic carcinoma | FAERS: 2 | US FAERS | |
| 172 | Pancreatic enzymes increased | FAERS: 2 | US FAERS | |
| 173 | Pancytopenia | FAERS: 2 | US FAERS | |
| 174 | Paraplegia | FAERS: 2 | US FAERS | |
| 175 | Pericarditis malignant | FAERS: 2 | US FAERS | |
| 176 | Productive Cough | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 177 | Proteinuria | FAERS: 2 | US FAERS | |
| 178 | Pulmonary toxicity | FAERS: 2 | US FAERS | |
| 179 | Sinus Tachycardia | FAERS: 2 | US FAERS | |
| 180 | Stomatitis | FAERS: 2 | US FAERS | |
| 181 | Sudden death | FAERS: 2 | US FAERS | |
| 182 | Supraventricular tachycardia | FAERS: 2 | US FAERS | |
| 183 | Swelling | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 184 | Syncope | FAERS: 2 | US FAERS | |
| 185 | Tachyarrhythmia | FAERS: 2 | US FAERS | |
| 186 | Therapy cessation | FAERS: 2 | US FAERS | |
| 187 | Therapy non-responder | FAERS: 2 Canada Vigilance: 3 | Canada Vigilance US FAERS | |
| 188 | Urinary Retention | FAERS: 2 | US FAERS | |
| 189 | Uterine Cancer | FAERS: 2 | US FAERS | |
| 190 | Viral pericarditis | FAERS: 2 | US FAERS | |
| 191 | Abasia | FAERS: 1 | US FAERS | |
| 192 | Abdominal mass | FAERS: 1 | US FAERS | |
| 193 | Abdominal rigidity | FAERS: 1 | US FAERS | |
| 194 | Acne | FAERS: 1 | US FAERS | |
| 195 | Activities of daily living impaired | FAERS: 1 | US FAERS | |
| 196 | Acute respiratory failure | FAERS: 1 | US FAERS | |
| 197 | Adverse event | FAERS: 1 | US FAERS | |
| 198 | Angioedema | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 199 | Anosmia | FAERS: 1 | US FAERS | |
| 200 | Anuria | FAERS: 1 | US FAERS | |
| 201 | Aphasia | FAERS: 1 | US FAERS | |
| 202 | Arthritis | FAERS: 1 | US FAERS | |
| 203 | Atelectasis | FAERS: 1 | US FAERS | |
| 204 | Back disorder | FAERS: 1 | US FAERS | |
| 205 | Bacterial sepsis | FAERS: 1 | US FAERS | |
| 206 | Biliary dilatation | FAERS: 1 | US FAERS | |
| 207 | Blighted ovum | FAERS: 1 | US FAERS | |
| 208 | Blindness | FAERS: 1 | US FAERS | |
| 209 | Blood albumin increased | FAERS: 1 | US FAERS | |
| 210 | Blood beta-D-glucan increased | FAERS: 1 | US FAERS | |
| 211 | Blood count abnormal | FAERS: 1 | US FAERS | |
| 212 | Bone marrow infiltration | FAERS: 1 | US FAERS | |
| 213 | Bone swelling | FAERS: 1 | US FAERS | |
| 214 | Bowel movement irregularity | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 215 | Brain Hypoxia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 216 | Bronchial secretion retention | FAERS: 1 | US FAERS | |
| 217 | Bronchiectasis | FAERS: 1 | US FAERS | |
| 218 | Bronchopulmonary Aspergillosis | FAERS: 1 | US FAERS | |
| 219 | Cancer Pain | FAERS: 1 | US FAERS | |
| 220 | Cauda Equina Syndrome | FAERS: 1 | US FAERS | |
| 221 | Cerebral calcification | FAERS: 1 | US FAERS | |
| 222 | Chromaturia | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 223 | Deafness | FAERS: 1 | US FAERS | |
| 224 | Deep Vein Thrombosis | FAERS: 1 | US FAERS | |
| 225 | Dementia | FAERS: 1 | US FAERS | |
| 226 | Desmoplastic melanoma | FAERS: 1 | US FAERS | |
| 227 | Device related infection | FAERS: 1 | US FAERS | |
| 228 | Dilatation intrahepatic duct acquired | FAERS: 1 | US FAERS | |
| 229 | Disorientation | FAERS: 1 | US FAERS | |
| 230 | Diverticulitis | FAERS: 1 | US FAERS | |
| 231 | Drug administration error | FAERS: 1 | US FAERS | |
| 232 | Drug dose omission | FAERS: 1 | US FAERS | |
| 233 | Dysuria | FAERS: 1 | US FAERS | |
| 234 | Electrolyte imbalance | FAERS: 1 | US FAERS | |
| 235 | Emotional disorder | FAERS: 1 | US FAERS | |
| 236 | Encephalomalacia | FAERS: 1 | US FAERS | |
| 237 | Epigastric discomfort | FAERS: 1 | US FAERS | |
| 238 | Eye pain | FAERS: 1 | US FAERS | |
| 239 | Fibrin D dimer decreased | FAERS: 1 | US FAERS | |
| 240 | Flushing | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 241 | Food craving | FAERS: 1 | US FAERS | |
| 242 | Fracture | FAERS: 1 | US FAERS | |
| 243 | Gastroenteritis | FAERS: 1 | US FAERS | |
| 244 | Gastrointestinal inflammation | FAERS: 1 | US FAERS | |
| 245 | Gastrointestinal sounds abnormal | FAERS: 1 | US FAERS | |
| 246 | Glucose tolerance increased | FAERS: 1 | US FAERS | |
| 247 | Grip strength decreased | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 248 | Hemiparesis | FAERS: 1 | US FAERS | |
| 249 | Hepatic Encephalopathy | FAERS: 1 | US FAERS | |
| 250 | Hepatic congestion | FAERS: 1 | US FAERS | |
| 251 | Hepatosplenomegaly | FAERS: 1 | US FAERS | |
| 252 | Histiocytosis haematophagic | FAERS: 1 | US FAERS | |
| 253 | Hypersensitivity | FAERS: 1 | US FAERS | |
| 254 | Hyperthyroidism | FAERS: 1 | US FAERS | |
| 255 | Hypokinesia | FAERS: 1 | US FAERS | |
| 256 | Hypophagia | FAERS: 1 | US FAERS | |
| 257 | Hypotension | FAERS: 1 | US FAERS | |
| 258 | Hypoxia | FAERS: 1 | US FAERS | |
| 259 | Impaired gastric emptying | FAERS: 1 | US FAERS | |
| 260 | Impaired work ability | FAERS: 1 | US FAERS | |
| 261 | Inappropriate schedule of product administration | FAERS: 1 | US FAERS | |
| 262 | Infectious pleural effusion | FAERS: 1 | US FAERS | |
| 263 | Intra-abdominal fluid collection | FAERS: 1 | US FAERS | |
| 264 | Janus kinase 2 mutation | FAERS: 1 | US FAERS | |
| 265 | Keratitis | FAERS: 1 | US FAERS | |
| 266 | Large intestine perforation | FAERS: 1 | US FAERS | |
| 267 | Leukopenia | FAERS: 1 | US FAERS | |
| 268 | Liver Abscess | FAERS: 1 | US FAERS | |
| 269 | Loss of personal independence in daily activities | FAERS: 1 | US FAERS | |
| 270 | Lung adenocarcinoma recurrent | FAERS: 1 | US FAERS | |
| 271 | Lymphangiosis carcinomatosa | FAERS: 1 | US FAERS | |
| 272 | Lymphangitis | FAERS: 1 | US FAERS | |
| 273 | Lymphopenia | FAERS: 1 | US FAERS | |
| 274 | Malignant ascites | FAERS: 1 | US FAERS | |
| 275 | Malnutrition | FAERS: 1 | US FAERS | |
| 276 | Maternal exposure during pregnancy | FAERS: 1 | US FAERS | |
| 277 | Mesothelioma | FAERS: 1 | US FAERS | |
| 278 | Metastases to abdominal cavity | FAERS: 1 | US FAERS | |
| 279 | Metastases to pelvis | FAERS: 1 | US FAERS | |
| 280 | Musculoskeletal discomfort | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 281 | Nasal discomfort | FAERS: 1 | US FAERS | |
| 282 | Necrosis | FAERS: 1 | US FAERS | |
| 283 | Nephrolithiasis | FAERS: 1 | US FAERS | |
| 284 | Nerve injury | FAERS: 1 | US FAERS | |
| 285 | Neuroblastoma | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 286 | Neurocysticercosis | FAERS: 1 | US FAERS | |
| 287 | Neurological decompensation | FAERS: 1 | US FAERS | |
| 288 | Neutrophil count abnormal | FAERS: 1 | US FAERS | |
| 289 | Nodule | FAERS: 1 | US FAERS | |
| 290 | Non-cardiac chest pain | FAERS: 1 | US FAERS | |
| 291 | Oesophagopleural fistula | FAERS: 1 | US FAERS | |
| 292 | Osteosclerosis | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 293 | Pancreatic duct dilatation | FAERS: 1 | US FAERS | |
| 294 | Paraparesis | FAERS: 1 | US FAERS | |
| 295 | Paresis | FAERS: 1 | US FAERS | |
| 296 | Pelvic Pain | FAERS: 1 | US FAERS | |
| 297 | Phlebitis | FAERS: 1 | US FAERS | |
| 298 | Pneumococcal sepsis | FAERS: 1 | US FAERS | |
| 299 | Pneumothorax | FAERS: 1 | US FAERS | |
| 300 | Positron emission tomogram abnormal | FAERS: 1 | US FAERS | |
| 301 | Post procedural complication | FAERS: 1 | US FAERS | |
| 302 | Procedural complication | FAERS: 1 | US FAERS | |
| 303 | Product dispensing error | FAERS: 1 | US FAERS | |
| 304 | Product quality issue | FAERS: 1 | US FAERS | |
| 305 | Pruritus | FAERS: 1 | US FAERS | |
| 306 | Psychiatric symptom | FAERS: 1 | US FAERS | |
| 307 | Pulmonary Hypertension | FAERS: 1 | US FAERS | |
| 308 | Pulmonary pain | FAERS: 1 | US FAERS | |
| 309 | Rash erythematous | FAERS: 1 | US FAERS | |
| 310 | Refeeding Syndrome | FAERS: 1 | US FAERS | |
| 311 | Regurgitation | FAERS: 1 | US FAERS | |
| 312 | Renal Cell Carcinoma | FAERS: 1 | US FAERS | |
| 313 | Renal mass | FAERS: 1 | US FAERS | |
| 314 | Restlessness | FAERS: 1 | US FAERS | |
| 315 | Retching | FAERS: 1 | US FAERS | |
| 316 | Retinal Vein Occlusion | FAERS: 1 | US FAERS | |
| 317 | Retroperitoneal mass | FAERS: 1 | US FAERS | |
| 318 | Rheumatoid Arthritis | FAERS: 1 | US FAERS | |
| 319 | Secretion discharge | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 320 | Septic Shock | FAERS: 1 | US FAERS | |
| 321 | Simple Partial Seizures | FAERS: 1 | US FAERS | |
| 322 | Sinus bradycardia | FAERS: 1 | US FAERS | |
| 323 | Skin Ulcer | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 324 | Skin lesion | FAERS: 1 | US FAERS | |
| 325 | Skin reaction | FAERS: 1 | US FAERS | |
| 326 | Splenic Rupture | FAERS: 1 | US FAERS | |
| 327 | Squamous cell carcinoma of lung | FAERS: 1 | US FAERS | |
| 328 | Squamous cell carcinoma | FAERS: 1 | US FAERS | |
| 329 | Suture related complication | FAERS: 1 | US FAERS | |
| 330 | Terminal state | FAERS: 1 | US FAERS | |
| 331 | Therapeutic response unexpected | FAERS: 1 | US FAERS | |
| 332 | Throat irritation | FAERS: 1 | US FAERS | |
| 333 | Toothache | FAERS: 1 | US FAERS | |
| 334 | Tremor | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 335 | Tuberculosis | FAERS: 1 | US FAERS | |
| 336 | Ulcer | FAERS: 1 | US FAERS | |
| 337 | Upper-airway cough syndrome | FAERS: 1 | US FAERS | |
| 338 | Vasculitis | FAERS: 1 | US FAERS | |
| 339 | Vocal Cord Paralysis | FAERS: 1 | US FAERS | |
| 340 | White matter lesion | FAERS: 1 | US FAERS | |
| 341 | jaundice | FAERS: 1 | US FAERS | |
| 342 | nervous system disorder | FAERS: 1 | US FAERS | |
| 343 | treatment failure | FAERS: 1 | US FAERS | |
| 344 | Electrocardiogram abnormal | Canada Vigilance: 1 | Canada Vigilance | |
| 345 | Hypersomnia | Canada Vigilance: 1 | Canada Vigilance | |
| 346 | Urine flow decreased | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120235
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.